These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Research to support pharmaceutical policies]. Wirtz VJ; Reich MR; Hernández-Avila M Salud Publica Mex; 2008; 50 Suppl 4():S427-8. PubMed ID: 19082252 [No Abstract] [Full Text] [Related]
45. Biotech drug market steadily expands. Lawrence S Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279 [No Abstract] [Full Text] [Related]
46. Creating effective medicinal chemistry collaborations in drug discovery. Giardina GA; Raveglia LF Future Med Chem; 2009 Apr; 1(1):3-6. PubMed ID: 21426065 [No Abstract] [Full Text] [Related]
47. More than meets the eyes? Jacobs T Nat Biotechnol; 2004 Oct; 22(10):1221. PubMed ID: 15470455 [No Abstract] [Full Text] [Related]
48. Pharmaceuticals and the developing world. Kremer M J Econ Perspect; 2002; 16(4):67-90. PubMed ID: 15179979 [No Abstract] [Full Text] [Related]
49. Market watch: Specialty pharmaceuticals to provide majority of sales by 2012. Goodman M Nat Rev Drug Discov; 2009 Mar; 8(3):184. PubMed ID: 19247297 [No Abstract] [Full Text] [Related]
50. Q&A: Alan Auerbach on small and speedy biotechs. Interview by Eric Bender. Auerbach A Cancer Discov; 2012 Mar; 2(3):198. PubMed ID: 22585977 [No Abstract] [Full Text] [Related]
51. Can complexity be commercialized? Mack GS Nat Biotechnol; 2004 Oct; 22(10):1223-9. PubMed ID: 15470456 [No Abstract] [Full Text] [Related]
52. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity. Berger JM Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292 [No Abstract] [Full Text] [Related]
53. Drug patent plan gets mixed reviews. Butler D Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077 [No Abstract] [Full Text] [Related]
54. Bugs or drugs, tortoises or hares? Jacobs T Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079 [No Abstract] [Full Text] [Related]
56. European collaboration on relative effectiveness will move into the next phase. Goettsch W J Comp Eff Res; 2013 Jan; 2(1):5-6. PubMed ID: 24236514 [No Abstract] [Full Text] [Related]
57. Pharmaceutical firms commit US$1 billion to antibiotic development. Mullard A Nat Rev Drug Discov; 2020 Sep; 19(9):575-576. PubMed ID: 32788679 [No Abstract] [Full Text] [Related]
58. Drug discovery: a modern decathlon. Laufer S; Holzgrabe U; Steinhilber D Angew Chem Int Ed Engl; 2013 Apr; 52(15):4072-6. PubMed ID: 23468378 [No Abstract] [Full Text] [Related]
59. The evolution of adaptiveness: balancing speed and evidence. Eichler HG; Barker R; Bedlington N; Bouvy JC; Broekmans AW; Bucsics A; Cerreta F; Corriol-Rohou S; Granados A; Le Cam Y; Schuurman A Nat Rev Drug Discov; 2018 Dec; 17(12):845-846. PubMed ID: 29977052 [No Abstract] [Full Text] [Related]
60. Understanding the value of information from pediatric clinical research. Ungar WJ Paediatr Drugs; 2012 Oct; 14(5):295-7. PubMed ID: 22897161 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]